Table 4 Lactobacilli crispatus viability testing of tenofovir and maraviroc bigel formulations
Formulations | Untreated growth yield (cfu) | Treated growth yield (cfu) | Log reduction (official limit not ≥ 1) |
|---|---|---|---|
BG A | 50 | 48 | 0.07 |
BG B | 50 | 46 | 0.036 |
BG C | 50 | 36 | 0.142 |
BG D | 50 | 35 | 0.155 |